Select Page

A personalized cancer vaccine developed with the help of a Mount Sinai computational platform raised no safety concerns and showed potential benefit in patients with different cancers, including lung…(PRWeb April 10, 2021)Read the full story at https://www.prweb.com/releases/personalized_cancer_vaccine_guided_by_mount_sinai_computations_is_safe_shows_potential_benefit_against_multiple_tumor_types/prweb17844223.htm

Read More